Taysha Gene Therapies Shares Tumble After $200M Public Offering

Taysha Gene Therapies' shares tumbled following the pricing of its public offering at $6.00 per share, aiming to raise $200 million. This news also comes as Hertz shares cratered due to its own stock offering and lowered guidance.